Parallax Volatility Advisers, L.P. Karuna Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $21 Million - $28.6 Million	118,900 New	118,900 $25.8 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $5.9 Million - $7.29 Million	30,800 Added 3850.0%	31,600 $6.21 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $99,032 - $221,936	800 New	800 $179,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.